Dizal (SSE:688192), a biopharmaceutical company committed to developing novel medicines for the treatment of cancer and ...

Participants with uncontrolled and otherwise treatment-resistant hypertension showed significant blood pressure improvement ...

Significant cognitive decline, increased depressive symptoms, and reduced self-care reported among those with heart failure.

Researchers at Cold Spring Harbor Laboratory have found that blocking the FGFR2 and EGFR genes can stop early-stage ...

During a live event, Xiuning Le, MD, PhD, discussed updated intracranial efficacy, overall survival, and safety of ...